UNRESECTABLE LEIOMYOSARCOMA
Clinical trials for UNRESECTABLE LEIOMYOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE LEIOMYOSARCOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE LEIOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare sarcomas: drug combo enters human testing
Disease control Recruiting nowThis early-phase trial tests a new two-drug combination for people with advanced soft tissue sarcomas that have spread or can't be removed by surgery. The study combines a standard chemotherapy (liposomal doxorubicin) with an experimental drug (peposertib) that may help the chemo…
Matched conditions: UNRESECTABLE LEIOMYOSARCOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 04:26 UTC
-
New hope for rare cancer: drug trial targets tumor growth
Disease control Recruiting nowThis study tests a drug called zanzalintinib (XL092) in 29 people with advanced leiomyosarcoma that has spread or cannot be removed by surgery. The drug works by blocking signals that help cancer cells grow. The goal is to see if it can slow the disease better than current treatm…
Matched conditions: UNRESECTABLE LEIOMYOSARCOMA
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated May 26, 2026 03:57 UTC